Anticoagulants: Updates on idarucizumab.
J S
JS
Chandan
T
T
Thomas
H S
HS
Baryah
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000991:Antithrombins / Q000009:adverse effects* / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects; D002986:Clinical Trials as Topic; D000069604:Dabigatran / Q000009:adverse effects* / Q000097:blood; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans
D061067:Antibodies, Monoclonal, Humanized; D000991:Antithrombins; C000594745:idarucizumab; D000069604:Dabigatran